1.Difficult endotracheal intubation due to an undiagnosed epiglottic cyst :A case report.
Jeoung Hyuk LEE ; Jun Gwon CHOI ; Dong Il YOON ; Youngmin LEE ; Junyong IN ; Seung Hyun CHUNG
Korean Journal of Anesthesiology 2009;56(5):567-570
An epiglottic cyst is a common form of laryngeal cysts which are rare causes of upper airway obstruction. A congenital laryngeal cyst always causes neonatal respiratory distress, but an acquired cyst shows very wide spectrum of symptoms such as no specific complaints, dysphagia, respiratory difficulty, or even death according to its size, location, or age. From anesthesiologists' point of view, an asymptomatic undiagnosed laryngeal cyst is a major concern. Unexpectedly, it can cause difficult airway such as 'cannnot intubate' or 'cannot intubate and cannot ventilate' situation during anesthesia. Recently we discovered an undiagnosed epiglottic cyst obscuring laryngeal inlet, leading to difficult intubation during general anesthesia for decompression and fusion of lumbar vertebrae. Fortunately, mask ventilation was possible, and after failed attempts of direct laryngoscopy, we could perform oral fiberoptic bronchoscope-aided intubation. He was discharged 10 days later with no harmful events.
Airway Obstruction
;
Anesthesia
;
Anesthesia, General
;
Bays
;
Bronchoscopes
;
Decompression
;
Deglutition Disorders
;
Intubation
;
Intubation, Intratracheal
;
Laryngoscopy
;
Lumbar Vertebrae
;
Masks
;
Ventilation
2.Affinity of Endothelial Cells to a Polyurethane Vascular Graft: A Preliminary Animal Study.
Seung Hyun AHN ; Youngmin JUN ; Hak CHANG ; Chung Hee PARK ; Kyung Won MINN
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2009;36(4):380-384
PURPOSE: Autologous vessels remain the gold standard for vascular grafts in microanastomoses. However, they are sometimes unavailable and have a limited long-term patency. Synthetic vessels have high success rates in large-diameter reconstructions but failed when used as small-diameter grafts due to graft occlusion. It has been proven that endothelial cell seeding improves prosthesis performance and long-term patency. Among polyurethane, PET and ePTFE, polyurethane has the best affinity to endothelial cells and mechanical properties closest to human vessels. We examined the ability of endothelial cells to attach to a polyurethane graft manufactured by the electrospinning method. METHODS: Endothelial cells, which were cultured from porcine internal jugular veins, were attached to polyurethane grafts with an internal diameter of 3mm. The same cells were attached to allogeneic decellularized porcine internal carotid artery grafts as controls. Both of the 10mm-long grafts were exposed to endothelial cells in a well for 1 hour. Each well contained 2x10(5) endothelial cells. The graft materials were rotated through 90 degrees every 15 minutes in order to minimize the effect of gravity. The extent of cell attachment was examined with the MTT assay. RESULTS: The MTT assay showed good incorporation of endothelial cells into both grafts. For the evaluation of affinity, the number of attached cells was counted at 10 fields of microscopic examination with x40 magnification. Endothelial cells adhered more to polyurethane grafts (mean, 127.4+/-6.2 cells) compared to porcine artery grafts (mean 45.8+/-5.1 cells)(p<0.05,Mann-Whitney test). CONCLUSION: In this study, we attached porcine endothelial cells to polyurethane grafts, manufactured by electrospinning. The grafts exhibited a better affinity to endothelial cells than allogeneic decellularized porcine internal carotid artery grafts. It is suggested that the time required for endothelial cells to attach to decellulized artery grafts may be longer than that which is required for attachment to polyurethane rafts.
Animals
;
Arteries
;
Carotid Artery, Internal
;
Endothelial Cells
;
Gravitation
;
Humans
;
Jugular Veins
;
Polyurethanes
;
Prostheses and Implants
;
Seeds
;
Transplants
3.Aspergillus Tracheobronchitis in a Mild Immunocompromised Host.
Byung Ha CHO ; Youngmin OH ; Eun Seok KANG ; Yong Joo HONG ; Hye Won JEONG ; Ok Jun LEE ; You Jin CHANG ; Kang Hyeon CHOE ; Ki Man LEE ; Jin Young AN
Tuberculosis and Respiratory Diseases 2014;77(5):223-226
Aspergillus tracheobronchitis is a form of invasive pulmonary aspergillosis in which the Aspergillus infection is limited predominantly to the tracheobronchial tree. It occurs primarily in severely immunocompromised patients such as lung transplant recipients. Here, we report a case of Aspergillus tracheobronchitis in a 42-year-old man with diabetes mellitus, who presented with intractable cough, lack of expectoration of sputum, and chest discomfort. The patient did not respond to conventional treatment with antibiotics and antitussive agents, and he underwent bronchoscopy that showed multiple, discrete, gelatinous whitish plaques mainly involving the trachea and the left bronchus. On the basis of the bronchoscopic and microbiologic findings, we made the diagnosis of Aspergillus tracheobronchitis and initiated antifungal therapy. He showed gradual improvement in his symptoms and continued taking oral itraconazole for 6 months. Physicians should consider Aspergillus tracheobronchitis as a probable diagnosis in immunocompromised patients presenting with atypical respiratory symptoms and should try to establish a prompt diagnosis.
Adult
;
Anti-Bacterial Agents
;
Antitussive Agents
;
Aspergillosis, Allergic Bronchopulmonary
;
Aspergillus*
;
Bronchi
;
Bronchoscopy
;
Cough
;
Diabetes Mellitus
;
Diagnosis
;
Gelatin
;
Humans
;
Immunocompromised Host*
;
Invasive Pulmonary Aspergillosis
;
Itraconazole
;
Lung
;
Sputum
;
Thorax
;
Trachea
;
Transplantation
4.Single Pleural Relapse of a Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma: A Case Report.
Keunmo KIM ; Youngmin OH ; Sung Nam LIM ; Song Yi CHOI ; Ok Jun LEE ; Kang Hyeon CHOE ; Ki Man LEE ; Jin Young AN
Tuberculosis and Respiratory Diseases 2014;76(4):184-187
A nasal-type extranodal natural killer/T-cell lymphoma is considered an aggressive form of non-Hodgkin's lymphoma, with approximately half of all patients relapsing during the follow-up period, and most relapses occurring within the first 2 years of remission. Here we report an unusual case of a 42-year-old man who experienced recurrence in single pleura after 8 years of remission.
Adenosine Deaminase
;
Adult
;
Follow-Up Studies
;
Humans
;
Lymphoma*
;
Lymphoma, Extranodal NK-T-Cell
;
Lymphoma, Non-Hodgkin
;
Pleura
;
Pleural Effusion
;
Recurrence*
5.Hypocapnia Attenuates, and Nitrous Oxide Disturbs the Cerebral Oximetric Response to the Rapid Introduction of Desflurane.
Younsuk LEE ; Jeoung Hyuk LEE ; Dong Il YOON ; Youngmin LEE ; Kyoung Ok KIM ; Seunghyun CHUNG ; Junyong IN ; Jun Gwon CHOI ; Hun CHO
Journal of Korean Medical Science 2009;24(6):1051-1057
The aim of this study was to develop a nonlinear mixed-effects model for the increase in cerebral oximetry (rSO2) during the rapid introduction of desflurane, and to determine the effect of hypocapnia and N2O on the model. Twelve American Society of Anesthesiologist physical status class 1 and 2 subjects were allocated randomly into an Air and N2O group. After inducing anesthesia, desflurane was then increased abruptly from 4.0 to 12.0%. The PET(CO2), PET(DESF) and rSO2 were recorded at 12 predetermined periods for the following 10 min. The maximum increase in rSO2 reached +24-25% during normocapnia. The increase in rSO2 could be fitted to a four parameter logistic equation as a function of the logarithm of PET(DESF). Hypocapnia reduced the maximum response of rSO2, shifted the EC50 to the right, and increased the slope in the Air group. N2O shifted the EC50 to the right, and reduced the slope leaving the maximum rSO2 unchanged. The N2O-effects disappeared during hypocapnia. The cerebrovascular reactivity of rSO2 to CO2 is still preserved during the rapid introduction of desflurane. N2O slows the response of rSO2. Hypocapnia overwhelms all the effects of N2O.
Adult
;
Anesthetics, Inhalation/*pharmacology
;
*Cerebral Cortex/blood supply/drug effects/physiology
;
Cerebrovascular Circulation/*drug effects/physiology
;
Female
;
Hemodynamics
;
Humans
;
Hypocapnia/*metabolism
;
Isoflurane/*analogs & derivatives/pharmacology
;
Male
;
Middle Aged
;
Models, Theoretical
;
Nitrous Oxide/*metabolism
;
*Oximetry
;
Random Allocation
;
Regional Blood Flow/drug effects
6.Intravenous Colistin Therapy for Multidrug-Resistant Gram-Negative Bacterial Infections in Major Burn Injuries
Gi yuon CHO ; Jaechul YOON ; Jin Woo CHUN ; Youngmin KIM ; Haejun YIM ; Dohern KYM ; Jun HUR ; Wook CHUN ; Yong Suk CHO
Journal of Korean Burn Society 2019;22(1):1-9
PURPOSE: The aim of this study was to investigate the characteristics of Acute Kidney Injury Network (AKIN)-defined nephrotoxicity in patients undergoing intravenous colistimethate sodium (CMS) therapy for major burns. METHODS: This retrospective study included burn patients who received more than 48 h of intravenous CMS between September 2009 and December 2015. Data collection was performed using the institution's electronic medical record system. Patients assigned to the developed nephrotoxic group experienced aggravation of current AKIN stage during CMS treatment; those assigned to the non-nephrotoxic group experienced no change in current or exhibited improved AKIN stage during CMS therapy. RESULTS: A total of 306 patients were included in this study. All patients were grouped according to AKIN stage: AKIN 0 (n=152); AKIN 1 (n=6); AKIN 2 (n=9); AKIN 3 (n=139). The baseline creatinine (Cr) level was 0.73 mg/dL. The incidence of nephrotoxicity was 50.3% according to AKIN stage; overall mortality was 45.8%. The non-nephrotoxic group consisted of 127 (74.7%) patients and 43 (25.3%) were in the developed nephrotoxic group. In patients requiring continuous renal replacement therapy (CRRT), baseline Cr level was 0.83 mg/dL, pre-CMS Cr level was 1.17 mg/dL, and post-CMS Cr level was 1.34 mg/dL. CONCLUSION: CMS can be administered without signs of nephrotoxicity for a certain period (approximately 1 week), it can be used relatively safely for 2 weeks. Application of CMS is a reasonable option for treating infections caused by multi-drug resistant gram-negative bacteria in patients with major burns. The caution should be exercised nevertheless.
Acute Kidney Injury
;
Burns
;
Colistin
;
Creatinine
;
Data Collection
;
Electronic Health Records
;
Gram-Negative Bacteria
;
Gram-Negative Bacterial Infections
;
Humans
;
Incidence
;
Mortality
;
Renal Replacement Therapy
;
Retrospective Studies
;
Sodium
7.Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment
Hayoung LEE ; Young Hoon KIM ; Seong Jun LIM ; Youngmin KO ; Sung SHIN ; Joo Hee JUNG ; Chung BAEK ; Hyosang KIM ; Su-Kil PARK ; Hyunwook KWON
Annals of Surgical Treatment and Research 2022;102(1):55-63
Purpose:
There are increased therapeutic usages of rituximab in kidney transplantation (KT). However, few studies have evaluated the effect of rituximab on cancer development following KT. This study aimed to evaluate the effect of rituximab on the cancer occurrence and mortality rate according to each type of cancer.
Methods:
Five thousand consecutive recipients who underwent KT at our center were divided into era1 (1990–2007) and era2-rit– (2008–2018), and era2-rit+ (2008–2018) groups. The era2-rit+ group included patients who received single-dose rituximab (200–500 mg) as a desensitization treatment 1–2 weeks before KT.
Results:
The 5-year incidence rates of malignant tumors after KT were 3.1%, 4.3%, and 3.5% in the era1, era2-rit–, and era2-rit+ group, respectively. The overall incidence rate of cancer after transplantation among the 3 study groups showed no significant difference (P = 0.340). The overall cancer-related mortality rate was 17.1% (53 of 310). Hepatocellular carcinoma (HCC) had the highest mortality rate (61.5%) and relative risk of cancer-related death (hazard ratio, 8.29; 95% confidence interval, 2.40–28.69; P = 0.001). However, we found no significant association between rituximab and the incidence of any malignancy.
Conclusion
Our results suggest that single-dose rituximab for desensitization may not increase the risk of malignant disease or cancer-related mortality in KT recipients. HCC was associated with the highest risk of cancer-related mortality in an endemic area of HBV infection.
8.Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Hye-Won JANG ; Chang Hee JUNG ; Youngmin KO ; Seong Jun LIM ; Hye Eun KWON ; Joo Hee JUNG ; Hyunwook KWON ; Young Hoon KIM ; Sung SHIN
Annals of Surgical Treatment and Research 2021;101(3):187-196
Purpose:
Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels and enhance the function of pancreatic βcells. Yet, it is unknown whether posttransplant administration of DPP4 inhibitors is beneficial for pancreas transplant recipients.
Methods:
We thus retrospectively analyzed the records of 312 patients who underwent pancreas transplantation between 2000 and 2018 at Asan Medical Center (Seoul, Korea) and compared the metabolic and survival outcomes according to DPP-4 inhibitor treatment.
Results:
The patients were divided into the no DPP-4 inhibitor group (n = 165; no treatment with DPP-4 inhibitors or treated for <1 month) and the DPP-4 inhibitor group (n = 147; treated with DPP-4 inhibitors for ≥1 month). There were no significant differences in levels of glucose, hemoglobin A1c, and insulin between the 2 groups during 36 months of follow-up. However, the level of C-peptide was significantly higher in the DPP-4 inhibitor group at 1, 6, and 24 months posttransplant (all P < 0.05). Moreover, the DPP-4 inhibitor group had significantly higher rates of overall (log-rank test, P = 0.009) and death-censored (log-rank test, P = 0.036) graft survival during a 15-year follow-up.
Conclusion
Posttransplant DPP-4 inhibitor administration may help improve the clinical outcomes including β cell function after pancreas transplantation.
9.Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Hye-Won JANG ; Chang Hee JUNG ; Youngmin KO ; Seong Jun LIM ; Hye Eun KWON ; Joo Hee JUNG ; Hyunwook KWON ; Young Hoon KIM ; Sung SHIN
Annals of Surgical Treatment and Research 2021;101(3):187-196
Purpose:
Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels and enhance the function of pancreatic βcells. Yet, it is unknown whether posttransplant administration of DPP4 inhibitors is beneficial for pancreas transplant recipients.
Methods:
We thus retrospectively analyzed the records of 312 patients who underwent pancreas transplantation between 2000 and 2018 at Asan Medical Center (Seoul, Korea) and compared the metabolic and survival outcomes according to DPP-4 inhibitor treatment.
Results:
The patients were divided into the no DPP-4 inhibitor group (n = 165; no treatment with DPP-4 inhibitors or treated for <1 month) and the DPP-4 inhibitor group (n = 147; treated with DPP-4 inhibitors for ≥1 month). There were no significant differences in levels of glucose, hemoglobin A1c, and insulin between the 2 groups during 36 months of follow-up. However, the level of C-peptide was significantly higher in the DPP-4 inhibitor group at 1, 6, and 24 months posttransplant (all P < 0.05). Moreover, the DPP-4 inhibitor group had significantly higher rates of overall (log-rank test, P = 0.009) and death-censored (log-rank test, P = 0.036) graft survival during a 15-year follow-up.
Conclusion
Posttransplant DPP-4 inhibitor administration may help improve the clinical outcomes including β cell function after pancreas transplantation.
10.Clinicoradiological features of resected serous cystic neoplasms according to morphological subtype and preoperative tentative diagnosis: can radiological characteristics distinguish serous cystic neoplasms from other lesions?
Jae Seung KANG ; Hyo Jun KIM ; Yoo Jin CHOI ; Yoonhyeong BYUN ; Jeong Min LEE ; Youngmin HAN ; Hongbeom KIM ; Wooil KWON ; Jin-Young JANG
Annals of Surgical Treatment and Research 2020;98(5):247-253
Purpose:
Serous cystic neoplasm (SCN) of the pancreas is considered benign in most cases. However, some SCN patients undergo surgical resection because lesions could not be differentiated preoperatively. This study evaluated causes of resection for SCN, investigated clinical and radiological features of surgically resected SCNs, and compared characteristics of SCNs diagnosed accurately and those misdiagnosed.
Methods:
One hundred patients, who underwent surgery for pancreatic cystic tumors with pathological confirmation of SCN between 2000 and 2014 were retrospectively analyzed.
Results:
The mean patient age was 52.9 years, 67 (67%) were female, and most lesions (72%) were located in the pancreatic body or tail. Fifty-one (51%) pathologically confirmed SCNs were preoperatively diagnosed as non-SCNs. Patients underwent surgery due to uncertain diagnosis (58%) or symptomatology (18%). According to radiological examination, most lesions were macrocystic (85%), exhibited septation (58%), or were enhancing lesions (48%). Compared with preoperatively diagnosed non-SCNs, accurately diagnosed SCNs exhibited septation (75.5% vs. 41.2%, P = 0.001) and central scar (36.7% vs. 11.8%, P = 0.003) more frequently in radiological examinations. In terms of macrocystic tumors (n = 85), most parameters did not differentiate preoperative diagnoses, although lesions accurately diagnosed as SCN exhibited septation more frequently than those preoperatively misdiagnosed as mucinous cystic neoplasm or intraductal papillary mucinous neoplasm (70.7% vs. 38.9% vs. 33.3%, respectively, P = 0.009).
Conclusion
It is difficult to accurately distinguish macrocystic SCNs from other cystic tumors using conventional radiological methods. For more accurate diagnosis, new biomarkers and/or other diagnostic modalities are needed and warrant further investigation.